science

We congratulate our colleagues and co-first authors Dr. Carsten Riether and Dr. Christian Schürch from the Ochsenbein Lab (Department of Clinical Research, University of Bern) on their outstanding publication in the highly ranked journal Science Translational Medicine. In thier study they present evidence that a combined therapy using Imatinib, a tyrosine kinase inhibitor, together with a CD70 blocking antibody is more efficient for the treatment of chronic myelogenous leukemia (CML) than the conventional approach with Imatinib alone. Find out more about their study here and here.

science

The University of Bern has released an interview with Dr. Eggel on the recently published Nature Medicine study in their online blog. He has contributed to this publication during his time as a post-doctoral fellow in the laboratory of Prof. Wyss-Cory at Stanford University.

sample

Dr. Saul A. Villeda and his team at UCSF have published an excellent story on the role of beta-2-microglobuline in cognitive function and neurogenesis in Nature Medicine this week. The groundwork for this study has been laid in the laboratory of Prof. Wyss-Coray at Stanford University. We are happy that we could contribute to this publication and congratulate all co-authors for this achievement. Read the publication here and have a look at Dr. Villeda's and Prof. Wyss-Coray's websites.   

science

The Veronika & Hugo Bohny Foundation honours young scientist who have conducted an outstanding bachelor thesis in an applied field of biomedical research. We are proud to announce that Pascal Gasser has been awarded 1st place of the 2015 call. As a part of our team Pascal has generated novel binding molecules against murine IgE for further in vivo use to test inhibition of allergic reactions. Here is a movie where he explains his work. Congratulations Pascal, this is well-deserved!

Open Positions

Are you interested in becoming the newest member of the Eggel Lab?

readmore

Contact Us

mapUniversity of Bern, Sahlihaus 2
CH-3010 Bern 

map+41 (0)31 632 22 87